Background Image
Menu

News: 2019

UKI2S, Catapult Ventures and Jonathan Milner invest £500k in Gene Modulation Newcomer Pencil Biosciences

12 December 2019

UKI2S, Catapult Ventures and Jonathan Milner invest £500k in Gene Modulation Newcomer Pencil Biosciences

11th December, 2019, Alderley Park: UK Innovation & Science Seed Fund (UKI2S), Catapult Ventures’ GM&C Life Sciences Fund and Jonathan Milner are pleased to announced an investment in Pencil Biosciences, a novel gene modulation company based at Alderley Park...

AMRC - Dr Peter Jackson article in Laboratory News

10 December 2019

AMRC - Dr Peter Jackson article in Laboratory News

Moving from Push to Pull … Nothing less than an entirely new model of drug development is needed if we are to create new antibiotics says Dr Peter Jackson. And it’s something NICE are finally taking seriously as they set about developing a new payment model – good...

AMR Centre - World Antibiotic Awareness Week

19 November 2019

AMR Centre - World Antibiotic Awareness Week

This week is World Antibiotic Awareness Week. Watch the video produced by the AMR Centre here:

AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

12 November 2019

AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

Alderley Park, UK, 11 November 2019 The AMR Centre has nominated a preclinical candidate in its program that tackles drug resistance conferred by NDM-1 and other metallo-β-lactamases (MBL). The MBL inhibitor (MBLI) research program will progress to clinical trials in 2020...

Nexus Labs selected for prestigious Accelerator Programme at Alderley Park

11 November 2019

Nexus Labs selected for prestigious Accelerator Programme at Alderley Park

We are delighted to share that Nexus Labs has been selected for the prestigious A ccelerator Programme at Alderley Park, po wered by BioCity. repres ented by CEO Glyn Estebanez, N exus will be one of 7 high-potential life-sciences start-ups supported by the programme over the...

No Photo

7 November 2019

Maxwellia's Anna Maxwell nominated for Top 50 Movers & Shakers in BioBusiness 2019

Anna Maxwell, from Catapult portfolio company Maxwellia, has been nominated as a Top 50 Mover & Shaker in BioBusiness 2019. Download the full report here https://bit.ly/34vKLEE

Biorelate launches AI-powered curation engine, Galactic, to combat the growing challenge of information overload in biomedicine.

21 October 2019

Biorelate launches AI-powered curation engine, Galactic, to combat the growing challenge of information overload in biomedicine.

Manchester, UK & San Diego, CA, 10 October 2019 – Biorelate, the AI company curating biomedical knowledge, today announces the launch of its proprietary tool for accelerated research intelligence, Galactic, at BioData World West 2019. Early adopters include McCann...

Gendius selected for Pitch@Palace 12.0

21 October 2019

Gendius selected for Pitch@Palace 12.0

Alderley Park, UK – 16 October 2019 … Gendius have been selected to go to St James palace next month as one of twelve companies to pitch for 3 minutes as part of this year’s prestigious pitch@palace . You can now help them improve the lives of people with diabetes by...

Patient feedback suggests that smart pill bottle could help improve adherence to critical medications

9 October 2019

Patient feedback suggests that smart pill bottle could help improve adherence to critical medications

MANCHESTER, UNITED KINGDOM, October 8, 2019 /EINPresswire.com/ -- Patient feedback suggests that smart pill bottle could help improve adherence to critical medications … A public focus group has responded positively to a smart pill bottle, Pill Connect, developed by eLucid...

2019 BioCap Call for Pitches Competition Winner Announced

8 October 2019

2019 BioCap Call for Pitches Competition Winner Announced

Bionow are delighted to announce QV Bioelectronics as the winner of the 2019 BioCap Call for Pitches Competition. The BioCap Call for Pitches Competition is a unique opportunity for companies who are seeking investment, to present to the international life science investment...